ATE336253T1 - Vitamin-d derivate zur behandlung des systemischen lupus erythematodes - Google Patents

Vitamin-d derivate zur behandlung des systemischen lupus erythematodes

Info

Publication number: ATE336253T1
Authority: AT; Austria
Prior art keywords: vitamin; death; derivatives; treatment; systemic lupus
Prior art date: 1999-04-29

Application number

AT00923617T

Other languages

English (en)

Inventor

Hector F Deluca

Margherita T Cantorna

Jean Humpal-Winter

Original Assignee

Wisconsin Alumni Res Found

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-04-29

Filing date

2000-04-25

Publication date

2006-09-15

2000-04-25 Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found

2006-09-15 Application granted granted Critical

2006-09-15 Publication of ATE336253T1 publication Critical patent/ATE336253T1/de

Links

206010015150 Erythema Diseases 0.000 title 1
231100000321 erythema Toxicity 0.000 title 1
206010025135 lupus erythematosus Diseases 0.000 title 1
230000009885 systemic effect Effects 0.000 title 1
150000003710 vitamin D derivatives Chemical class 0.000 title 1
208000024891 symptom Diseases 0.000 abstract 3
229930003316 Vitamin D Natural products 0.000 abstract 1
QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 abstract 1
235000019166 vitamin D Nutrition 0.000 abstract 1
239000011710 vitamin D Substances 0.000 abstract 1
-1 vitamin D compound Chemical class 0.000 abstract 1
229940046008 vitamin d Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Inorganic Chemistry (AREA)
Hematology (AREA)
Diabetes (AREA)
Obesity (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

AT00923617T 1999-04-29 2000-04-25 Vitamin-d derivate zur behandlung des systemischen lupus erythematodes ATE336253T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US30197099A	1999-04-29	1999-04-29
US09/422,571 US6673782B2 (en)	1999-04-29	1999-10-21	Treatment of systemic lupus erythematosis

Publications (1)

Publication Number	Publication Date
ATE336253T1 true ATE336253T1 (de)	2006-09-15

Family

ID=26972694

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT00923617T ATE336253T1 (de)	1999-04-29	2000-04-25	Vitamin-d derivate zur behandlung des systemischen lupus erythematodes

Country Status (9)

Country	Link
US (2)	US6673782B2 (de)
EP (1)	EP1181020B1 (de)
JP (1)	JP2002543115A (de)
AT (1)	ATE336253T1 (de)
AU (1)	AU4370900A (de)
CA (1)	CA2370230C (de)
DE (1)	DE60030107T2 (de)
ES (1)	ES2270825T3 (de)
WO (1)	WO2000066098A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6479474B2 (en) *	1999-07-08	2002-11-12	Wisconsin Alumni Research Foundation	Dietary calcium as a supplement to vitamin D compound treatment of multiple sclerosis
US20070037740A1 (en) *	2003-03-04	2007-02-15	Irit Pinchasi	Combination therapy with glatiramer acetate and alphacalcidol for the treatment of multiple sclerosis
AU2004266706B2 (en) *	2003-08-20	2009-07-30	Wisconsin Alumni Research Foundation	2-methylene-19-nor-vitamin D2 compounds
WO2006086661A2 (en) *	2005-02-10	2006-08-17	Above Sea Level, Llc	Lead generation method and system
NZ561076A (en) *	2005-02-11	2010-01-29	Wisconsin Alumni Res Found	2-methylene-19-nor-(20S-24EPI)-1alpha,25-dihydroxyvitamin-D2
AU2006213727B2 (en) *	2005-02-11	2011-08-18	Wisconsin Alumni Research Foundation	2-methylene-19-nor- (20S-24S) - 1alpha, 25-dihydroxyvitamin-D2
WO2010120698A1 (en) *	2009-04-17	2010-10-21	Vidasym, Llc	Vitamin d receptor agonists and uses thereof
US20110034426A1 (en) *	2009-08-03	2011-02-10	Wisconsin Alumni Research Foundation	Method of Preventing Renal Disease and Treating Symptoms Thereof
SG11201408731WA (en)	2012-06-29	2015-01-29	Wisconsin Alumni Res Found	USE OF 2-METHYLENE-19-NOR-(20S)-1α,25-DIHYDROXYVITAMIN D<sb>3</sb> TO TREAT SECONDARY HYPERPARATHYROIDISM
US9539264B2 (en)	2014-12-30	2017-01-10	Wisconsin Alumni Research Foundation	Use of 2-methylene-19-nor-(20S)-1-alpha,25-dihydroxyvitamin D3 to treat secondary hyperparathyroidism in patients previously treated with calcimimetics
US10369161B2 (en)	2014-12-30	2019-08-06	Wisconsin Alumni Research Foundation	Use of 2-methylene-19-NOR-(20S)-1-alpha,25-dihydroxyvitamin D3 to treat primary hyperparathyroidism
US11480568B2 (en) *	2017-09-28	2022-10-25	Yeda Research And Development Co. Ltd.	Diagnosis of autoimmune diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5891865A (en)	1996-10-04	1999-04-06	Wisconsin Alumni Research Foundation	Treatment of arthritic disease induced by infectious agents
US6030962A (en) *	1997-04-28	2000-02-29	Synttex (U.S.A.) Inc.	Vitamin D3 analogs with bis C-20 side chains

1999
- 1999-10-21 US US09/422,571 patent/US6673782B2/en not_active Expired - Fee Related
2000
- 2000-04-25 AT AT00923617T patent/ATE336253T1/de not_active IP Right Cessation
- 2000-04-25 EP EP00923617A patent/EP1181020B1/de not_active Expired - Lifetime
- 2000-04-25 AU AU43709/00A patent/AU4370900A/en not_active Abandoned
- 2000-04-25 JP JP2000614983A patent/JP2002543115A/ja active Pending
- 2000-04-25 CA CA002370230A patent/CA2370230C/en not_active Expired - Fee Related
- 2000-04-25 ES ES00923617T patent/ES2270825T3/es not_active Expired - Lifetime
- 2000-04-25 WO PCT/US2000/011104 patent/WO2000066098A2/en not_active Ceased
- 2000-04-25 DE DE60030107T patent/DE60030107T2/de not_active Expired - Lifetime
2004
- 2004-01-05 US US10/751,802 patent/US20040142912A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CA2370230C (en)	2009-12-08
EP1181020B1 (de)	2006-08-16
DE60030107D1 (de)	2006-09-28
WO2000066098A3 (en)	2001-05-31
US20040142912A1 (en)	2004-07-22
US6673782B2 (en)	2004-01-06
CA2370230A1 (en)	2000-11-09
WO2000066098A2 (en)	2000-11-09
AU4370900A (en)	2000-11-17
DE60030107T2 (de)	2007-04-19
ES2270825T3 (es)	2007-04-16
JP2002543115A (ja)	2002-12-17
EP1181020A2 (de)	2002-02-27
US20020028830A1 (en)	2002-03-07

Similar Documents

Publication	Publication Date	Title
IL172705A0 (en)	2006-04-10	Use of [3.2.0] heterocyclic compounds and analogs thereof for the treatment of cancer, inflammation and infectious diseases
EA200601799A1 (ru)	2007-04-27	Гидразидсодержащие соединения - ингибиторы cftr и их применение
CY1109242T1 (el)	2014-07-02	Θεραπευτικοι παραγοντες χρησιμοι για θεραπεια πονου
PT880350E (pt)	2002-04-29	Tratamento de esclerose multipla
ATE336253T1 (de)	2006-09-15	Vitamin-d derivate zur behandlung des systemischen lupus erythematodes
DE60316779D1 (de)	2007-11-22	Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
EA200501023A1 (ru)	2005-12-29	Терапевтические составы для лечения болезней, связанных с наличием бета-амилоида
BR0212252A (pt)	2004-09-14	Métodos para reduzir a hipertensão e a insuficiência cardìaca em um mamìfero
DE3586859D1 (de)	1993-01-07	Mittel zur behandlung und zum schutz der haut.
PL356252A1 (en)	2004-06-28	Synergistic combination of pde inhibitors and beta 2 adrenoceptor agonist
DE69512589D1 (de)	1999-11-11	Behandlung von durch Talgdrüse verursachten Erkrankungen mit Inhibitoren der Acyl CoA Cholesterin Acyltransferase
DE602006010442D1 (de)	2009-12-24	Verwendung von benzokondensierten heterocyclischen sulfamid-derivaten zur behandlung von schmerzen
ATE141045T1 (de)	1996-08-15	Schlankmachende zusammensetzung
NO994330L (no)	1999-10-25	Metode for behandling av en tumor
BG105875A (en)	2002-05-31	Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of diabetic retinopathy
NO20050718L (no)	2005-04-01	Topikal behandling av hudsykdommer
NO20006506L (no)	2001-02-21	Anvendelse av valproinsyreanalog for behandlingen og forebyggelsen av migrene og affektive sykdommer
PT986393E (pt)	2004-06-30	Utilizacao de um nitroxido ou de um seu pro-farmaco no tratamento profilactico e terapeutico do cancro
NO20055390L (no)	2006-01-16	Thorium-227 for anvendelse i radioterapi pa mykvevssykdommer
ATE333897T1 (de)	2006-08-15	Arzneimittel mit chymaseinhibitoren als wirksames mittel zur behandlung von dermatitis mit zweiphasigen hautreaktionen
GEP20043231B (en)	2004-05-25	Resorcinol Composition
CY1105564T1 (el)	2010-07-28	Θεραπεια συνδυασμου για καρκινο
BR0315374A (pt)	2005-08-23	Compostos orgânicos
TR200202033T2 (tr)	2003-01-21	Epilepsi Tedavisi İçin Terkipler ve Yöntemler
DE60024408D1 (de)	2006-01-05	Verwendung von trizyklischen antidepressiva zur behandlung von kopfschmerzen

Legal Events

Date	Code	Title	Description
2007-02-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties